文献速递头颈部肿瘤放疗放疗物理与技术

头颈部肿瘤动态轨迹放疗的危及器官保护:在公开病例库上与容积旋转调强放疗的比较

Organ-at-risk sparing with dynamic trajectory radiotherapy for head and neck cancer: comparison with volumetric arc therapy on a publicly available library of cases.
PubMed 文献 · Radiat Oncol · 2022-07-15

本研究在包含7例头颈部肿瘤病例的公开模体库上建立动态轨迹放疗(DTRT)的路径规划策略,验证其可实施性与剂量学精度,并与容积旋转调强放疗(VMAT)比较。DTRT与VMAT靶区覆盖相似,在部分口咽癌、腺样囊性癌、鼻咽癌、喉癌及单侧声带照射病例中显示出降低部分危及器官剂量的潜力,所有计划均成功在模体上实施。

要点

  • 在7例头颈部肿瘤模体病例中DTRT与VMAT靶区覆盖相似。
  • 3例局部晚期口咽癌和1例腺样囊性癌中DTRT平均降低对侧唾液腺、咽和口腔剂量。
  • 所有DTRT计划均在C臂直线加速器上成功实施,剂量验证伽马通过率为93.9%和95.8%。

核心结论

  • 本研究为常见头颈部肿瘤病例的DTRT提供了原理验证,计划可在C臂直线加速器上以高精度实施。
  • 与VMAT的比较表明DTRT可实现可观的危及器官保护。

研究设计与样本

  • 在拟人模体上建立包含7例头颈部肿瘤病例的公开病例库,并勾画所有相关危及器官。
  • DTRT计划采用使靶区/危及器官体积重叠最小化的射束入射方向生成,并与VMAT比较。
  • 在模体上进行可实施性与剂量学验证。

主要发现

  • DTRT与VMAT靶区覆盖相似。
  • 3例局部晚期口咽癌和1例腺样囊性癌中,DTRT较VMAT平均降低对侧唾液腺、咽和口腔剂量分别为2.5 Gy、1.7 Gy和3.1 Gy。
  • 1例局部复发鼻咽癌中,同侧视神经D0.03 cc在VMAT为54.8 Gy(超过54.0 Gy耐受量),在DTRT为53.3 Gy(在耐受量内)。
  • 1例喉癌中,DTRT较VMAT对咽和臂丛剂量更高,但对上段食管、甲状腺和对侧颈动脉剂量更低。
  • 1例单侧声带照射病例中,DTRT对多数危及器官的保护优于VMAT。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dynamic trajectory radiotherapy (DTRT) extends volumetric modulated arc therapy (VMAT) with dynamic table and collimator rotation during beam-on. The aim of the study is to establish DTRT path-finding strategies, demonstrate deliverability and dosimetric accuracy and compare DTRT to state-of-the-art VMAT for common head and neck (HN) cancer cases. METHODS: A publicly available library of seven HN cases was created on an anthropomorphic phantom with all relevant organs-at-risk (OARs) delineated. DTRT plans were generated with beam incidences minimizing fractional target/OAR volume overlap and compared to VMAT. Deliverability and dosimetric validation was carried out on the phantom. RESULTS: DTRT and VMAT had similar target coverage. For three locoregionally advanced oropharyngeal carcinomas and one adenoid cystic carcinoma, mean dose to the contralateral salivary glands, pharynx and oral cavity was reduced by 2.5, 1.7 and 3.1 Gy respectively on average with DTRT compared to VMAT. For a locally recurrent nasopharyngeal carcinoma, D0.03 cc to the ipsilateral optic nerve was above tolerance (54.0 Gy) for VMAT (54.8 Gy) but within tolerance for DTRT (53.3 Gy). For a laryngeal carcinoma, DTRT resulted in higher dose than VMAT to the pharynx and brachial plexus but lower dose to the upper oesophagus, thyroid gland and contralateral carotid artery. For a single vocal cord irradiation case, DTRT spared most OARs better than VMAT. All plans were delivered successfully on the phantom and dosimetric validation resulted in gamma passing rates of 93.9% and 95.8% (2%/2 mm criteria, 10% dose threshold). CONCLUSIONS: This study provides a proof of principle of DTRT for common HN cases with plans that were deliverable on a C-arm linac with high accuracy. The comparison with VMAT indicates substantial OAR sparing could be achieved.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Bertholet J, Mackeprang PH, Mueller S, et al. Organ-at-risk sparing with dynamic trajectory radiotherapy for head and neck cancer: comparison with volumetric arc therapy on a publicly available library of cases. Radiat Oncol. 2022. PMID: 35841098. doi:10.1186/s13014-022-02092-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。